Cargando…

Living Donor Liver Transplantation in Patients with Preformed Donor-Specific Anti-Human Leukocyte Antigen Antibodies Using Preoperative Desensitization Therapy According to Intensity of Donor-Specific Antibodies: A Single-Center Study

BACKGROUND: In liver transplantation (LT), preoperative desensitization therapy is considered necessary in patients positive for donor-specific anti-human leukocyte antigen antibodies (DSAs). However, the relationship between DSA intensity and the necessary desensitization therapy is unclear. MATERI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ogawa, Kohei, Tamura, Kei, Sakamoto, Katsunori, Funamizu, Naotake, Honjo, Masahiko, Shine, Mikiya, Nishi, Yusuke, Nagaoka, Tomoyuki, Ito, Chihiro, Iwata, Miku, Uraoka, Mio, Takada, Yasutsugu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2023
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504854/ https://www.ncbi.nlm.nih.gov/pubmed/37697637 http://dx.doi.org/10.12659/AOT.941346

Ejemplares similares

Diagnostic value of quantification of cell‐free DNA for suspected gallbladder cancer
por: Sakamoto, Katsunori, et al.
Publicado: (2023)

Association between the Preoperative C-Reactive Protein-to-Albumin Ratio and the Risk for Postoperative Pancreatic Fistula following Distal Pancreatectomy for Pancreatic Cancer
por: Funamizu, Naotake, et al.
Publicado: (2022)

Usefulness of a Balloon Catheter for Intraoperative Cholangiography During Living Donor Hepatectomy: A Product Investigation
por: Sakamoto, Katsunori, et al.
Publicado: (2020)

Preoperative C-Reactive Protein-to-Albumin Ratio Predicts Postoperative Pancreatic Fistula following Pancreatoduodenectomy: A Single-Center, Retrospective Study
por: Funamizu, Naotake, et al.
Publicado: (2022)

Intraoperative selective arterial calcium injection test to confirm complete resection of a proinsulinoma
por: Sakamoto, Akimasa, et al.
Publicado: (2022)

Rituximab Desensitization in Liver Transplant Recipients With Preformed Donor-specific HLA Antibodies: A Japanese Nationwide Survey
por: Akamatsu, Nobuhisa, et al.
Publicado: (2021)

Laparoscopic partial liver resection for hepatocellular carcinoma arising from Fontan-associated liver disease: a case report
por: Iwata, Miku, et al.
Publicado: (2021)

Geriatric nutritional risk index as a potential prognostic marker for patients with resectable pancreatic cancer: a single-center, retrospective cohort study
por: Funamizu, Naotake, et al.
Publicado: (2022)

The impact of preformed donor‐specific antibodies in living donor liver transplantation according to graft volume
por: Goto, Ryoichi, et al.
Publicado: (2022)

Long-term survival from progressive multifocal leukoencephalopathy in living-donor liver transplant recipient with preformed donor-specific antibody
por: Egashira, Shuhei, et al.
Publicado: (2023)

Preformed Donor-specific Antibodies Against HLA Class II and Graft Outcomes in Deceased-donor Kidney Transplantation
por: Uffing, Audrey, et al.
Publicado: (2019)

Living Donor Kidney Transplantation in Patients With Donor-Specific HLA Antibodies After Desensitization With Immunoadsorption
por: Kälble, Florian, et al.
Publicado: (2021)

Desensitization using IVIG alone for living-donor kidney transplant: impact on donor-specific antibodies
por: Ulisses, Luiz Roberto de Sousa, et al.
Publicado: (2022)

Safety and efficacy of eculizumab for the prevention of antibody‐mediated rejection after deceased‐donor kidney transplantation in patients with preformed donor‐specific antibodies
por: Glotz, Denis, et al.
Publicado: (2019)

Laparoscopic remnant cholecystectomy for calculi in the remnant gallbladder following subtotal-cholecystectomy: a report of two cases
por: Utsunomiya, Takeshi, et al.
Publicado: (2021)

Combined Liver-Kidney Transplantation With Preformed Anti–human Leukocyte Antigen Donor-Specific Antibodies
por: Del Bello, Arnaud, et al.
Publicado: (2020)

Early and Sustained Reduction in Donor-Specific Antibodies in Desensitized Living Donor Kidney Transplant Recipients: A 3-Year Prospective Study
por: Shaffer, David, et al.
Publicado: (2016)

Effect of donor-specific antibodies and panel reactive antibodies in living donor liver transplant recipients
por: Song, Seung Hwan, et al.
Publicado: (2015)

Impact of Resolved Preformed, Persistent Preformed, and De Novo Anti-HLA Donor-Specific Antibodies in Kidney Transplant Recipients on Long-Term Renal Graft Outcomes
por: Gniewkiewicz, Michal, et al.
Publicado: (2023)

Immunology and Donor-Specific Antibodies in Corneal Transplantation
por: Major, Joanna, et al.
Publicado: (2021)

Behaviour of Non-Donor Specific Antibodies during Rapid Re-Synthesis of Donor Specific HLA Antibodies after Antibody Incompatible Renal Transplantation
por: Krishnan, Nithya S., et al.
Publicado: (2013)

Significance of Semiquantitative Assessment of Preformed Donor-Specific Antibody Using Luminex Single Bead Assay in Living Related Liver Transplantation
por: Yoshizawa, Atsushi, et al.
Publicado: (2013)

Differential effects of donor‐specific HLA antibodies in living versus deceased donor transplant
por: Kamburova, E. G., et al.
Publicado: (2018)

Donor specific HLA antibody in hematopoietic stem cell transplantation: Implications for donor selection
por: Krummey, Scott M., et al.
Publicado: (2022)

Impact of Preformed Donor-Specific Anti-Human Leukocyte Antigen Antibody C1q-Binding Ability on Kidney Allograft Outcome
por: Molina, Juan, et al.
Publicado: (2017)

microRNAs Associated with Gemcitabine Resistance via EMT, TME, and Drug Metabolism in Pancreatic Cancer
por: Funamizu, Naotake, et al.
Publicado: (2023)

Prognostic Role of the Intrahepatic Lymphatic System in Liver Cancer
por: Sakamoto, Katsunori, et al.
Publicado: (2023)

Donor-specific antibodies development in renal living-donor receptors: Effect of a single cohort
por: Andrade-Sierra, Jorge, et al.
Publicado: (2021)

Daratumumab for donor-specific anti-HLA antibody desensitization in a case of HLA-mismatched allogeneic stem cell transplantation
por: Ibrahim, Uroosa, et al.
Publicado: (2023)

Donor-derived Cell-free DNA Identifies Antibody-mediated Rejection in Donor Specific Antibody Positive Kidney Transplant Recipients
por: Jordan, Stanley C., et al.
Publicado: (2018)

Impact of Donor-Specific anti-HLA Antibodies and Donor KIR Characteristics in Haploidentical HSCT for Beta-Thalassemia
por: Andreani, Marco, et al.
Publicado: (2017)

Characteristics of Donor-Specific Antibodies Associated With Antibody-Mediated Rejection in Lung Transplantation
por: Roux, Antoine, et al.
Publicado: (2017)

Prognostic Impact of Surgical Margin Width in Hepatectomy for Colorectal Liver Metastasis
por: Sakamoto, Katsunori, et al.
Publicado: (2023)

Impact of preformed donor-specific antibodies against HLA class I on kidney graft outcomes: Comparative analysis of exclusively anti-Cw vs anti-A and/or -B antibodies
por: Santos, Sofia, et al.
Publicado: (2016)

Diagnostic value of donor‐derived cell‐free DNA to predict antibody‐mediated rejection in donor‐specific antibody‐positive renal allograft recipients
por: Mayer, Katharina A., et al.
Publicado: (2021)

Antibody-mediated Rejection Without Detectable Donor-specific Antibody Releases Donor-derived Cell-free DNA: Results From the Trifecta Study
por: Halloran, Philip F., et al.
Publicado: (2023)

The Prevalence of Yersinia Yop-Specific Iga Antibodies in Iranian Healthy Blood Donors and Evaluation of Blood Culture of Seropositive Donors
por: TIMORI NAGHADEH, Hossein, et al.
Publicado: (2016)

Dengue antibodies in blood donors
por: Ribas-Silva, Rejane Cristina, et al.
Publicado: (2012)

Utility of Protocol Pancreas Biopsies for De Novo Donor-specific Antibodies
por: Parajuli, Sandesh, et al.
Publicado: (2022)

Impact of preformed T-cell alloreactivity by means of donor-specific and panel of reactive T cells (PRT) ELISPOT in kidney transplantation
por: Gandolfini, Ilaria, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_votn94b2b4ju5bc56e9g1bcea1